Recent Advances in the Development of Mammalian Geranylgeranyl Diphosphate Synthase Inhibitors

被引：27

作者：

Haney, Staci L. ^{[1
]}

Wills, Veronica S. ^{[2
]}

Wiemer, David F. ^{[2
]}

Holstein, Sarah A. ^{[1
]}

机构：

[1] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA

[2] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA

来源：

MOLECULES | 2017年 / 22卷 / 06期

基金：

美国国家卫生研究院;

关键词：

geranylgeranyl diphosphate synthase; isoprenoid; geranylgeranylation; inhibitors; NITROGEN-CONTAINING BISPHOSPHONATES; MULTIPLE-MYELOMA CELLS; ISOPRENOID BISPHOSPHONATES; TRIAZOLE BISPHOSPHONATES; PYROPHOSPHATE SYNTHASE; REDUCTASE INHIBITORS; MEVALONATE PATHWAY; PROTEIN PRENYLATION; BONE-RESORPTION; LOVASTATIN;

D O I：

10.3390/molecules22060886

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The enzyme geranylgeranyl diphosphate synthase (GGDPS) catalyzes the synthesis of the 20-carbon isoprenoid geranylgeranyl diphosphate (GGPP). GGPP is the isoprenoid donor for protein geranylgeranylation reactions catalyzed by the enzymes geranylgeranyl transferase (GGTase) I and II. Inhibitors of GGDPS result in diminution of protein geranylgeranylation through depletion of cellular GGPP levels, and there has been interest in GGDPS inhibitors as potential anti-cancer agents. Here we discuss recent advances in the development of GGDPS inhibitors, including insights gained by structure-function relationships, and review the preclinical data that support the continued development of this novel class of drugs.

引用

页数：12

共 50 条

[21] Characterization of Potential Drug Targets Farnesyl Diphosphate Synthase and Geranylgeranyl Diphosphate Synthase in Schistosoma mansoni
Ziniel, Peter D.
Desai, Janish
Cass, Cynthia L.
Gatto, Craig
Oldfield, Eric
Williams, David L.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (12) : 5969 - 5976
[22] Preclinical investigation of a potent geranylgeranyl diphosphate synthase inhibitor
Haney, Staci L.
Chhonker, Yashpal S.
Varney, Michelle L.
Talmon, Geoffrey
Murry, Daryl J.
Holstein, Sarah A.
INVESTIGATIONAL NEW DRUGS, 2018, 36 (05) : 810 - 818
[23] Preclinical investigation of a potent geranylgeranyl diphosphate synthase inhibitor
Staci L. Haney
Yashpal S. Chhonker
Michelle L. Varney
Geoffrey Talmon
Daryl J. Murry
Sarah A. Holstein
Investigational New Drugs, 2018, 36 : 810 - 818
[24] Human geranylgeranyl diphosphate synthase - cDNA cloning and expression
Kuzuguchi, T
Morita, Y
Sagami, I
Sagami, H
Ogura, K
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (09) : 5888 - 5894
[25] Moiety-Linkage Map Reveals Selective Nonbisphosphonate Inhibitors of Human Geranylgeranyl Diphosphate Synthase
Chen, Shih-Hsun
Lin, Sheng-Wei
Lin, Shen-Rong
Liang, Po-Huang
Yang, Jinn-Moon
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2013, 53 (09) : 2299 - 2311
[26] Preclinical Investigation of a Potent Geranylgeranyl Diphosphate Synthase Inhibitor
Haney, Staci L.
Chhonker, Yashpal S.
Varney, Michelle L.
Talmon, Geoffrey A.
Murry, Daryl J.
Holstein, Sarah A.
BLOOD, 2017, 130
[27] Specificity of geranylgeranyl diphosphate synthase for homoallylic substrate analogs
Ohya, Norimasa
Ichijo, Takumi
Sato, Hana
Nakamura, Takeshi
Yokota, Saki
Sagami, Hiroshi
Nagaki, Masahiko
JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC, 2015, 120 : 179 - 182
[28] Potent Triazole Bisphosphonate Inhibitor of Geranylgeranyl Diphosphate Synthase
Wills, Veronica S.
Allen, Cheryl
Holstein, Sarah A.
Wiemer, David F.
ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (12): : 1195 - 1198
[29] Recent Advances in the Development of Fatty Acid Synthase Inhibitors as Anticancer Agents
Singh, Shailendra
Karthikeyan, Chandrabose
Moorthy, N. S. Hari Narayana
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2020, 20 (18) : 1820 - 1837
[30] Recent Advances in the Development of Undecaprenyl Pyrophosphate Synthase Inhibitors as Potential Antibacterials
Jukic, Marko
Rozman, Kaja
Gobec, Stanislav
CURRENT MEDICINAL CHEMISTRY, 2016, 23 (05) : 464 - 482

← 1 2 3 4 5 →